We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electronic Fetal Heart Rate Monitoring Reduces Infant Mortality

By HospiMedica International staff writers
Posted on 01 Mar 2011
A new study shows that the use of electronic fetal heart rate monitoring (EFM) lowers the rate of infant mortality. More...


Researchers at the University of Dentistry and Medicine of New Jersey (UMDNJ; New Brunswick, USA) and Winthrop University Hospital (Mineola, NY; USA) analyzed data from a sample of 1,945,789 singleton infant birth and death records from the 2004 US National Birth Cohort. Multivariable log-binomial regression models were fitted to estimate risk ratio (RR) to evaluate the association between EFM and mortality, while adjusting for age, race, marital status, education, smoking, and the infant's gender; 89% of singleton pregnancies had EFM.

The results showed that EFM was associated with significantly lower infant mortality; this was mainly driven by the lower risk of early neonatal mortality. In low-risk pregnancies, EFM was associated with decreased risk for low (less than 4) 5-min Apgar scores, whereas in high-risk pregnancies EFM was also associated with decreased risk of neonatal seizures. In all, the use of EFM decreased early neonatal mortality by 53%. The study was presented at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, held during February 2011 in San Francisco (CA, USA).

"There was some criticism within the obstetric community that fetal heart rate monitoring was quickly accepted technology without proof that it was effective," said study coauthor Suneet Chauhan, MD. "We thought we could use data from the National Birth Cohort to get a large enough sample to gauge its effectiveness.”

EFM is done during pregnancy, labor, and delivery to keep track of the heart rate of the fetus and the strength and duration of the contractions of the uterus.

Related Links:
University of Dentistry and Medicine of New Jersey
Winthrop University Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.